Mariam F. Eskander, MD, MPH, and Coral O. Omene, MD, PhD, discuss potential strategies that teams can implement to ensure clinical trials are more representative of the general population.
CUSP06 received fast track designation from the FDA for patients with platinum-resistant ovarian cancer.
Get a synopsis of the top hematology research presented at the latest ASH annual meeting and learn how it can help improve your patient management…
Experts provide insights on the 2024 FDA approvals in several different fields including solid tumors and more in this list featuring the regulatory decisions.
Catherine C. Coombs, MD, discusses the challenges in establishing a treatment consensus for relapsed CLL.
Health Canada has approved perioperative pembrolizumab for resectable non–small cell lung cancer.
Join us for the SGO 2025 Annual Meeting on Women’s Cancer Masterclasses, crafted to advance your professional development and empower you to provide exceptional and…
Format Live, In-Person Event *Pre-registration required Live interactive continuing medical education activity for healthcare professionals in Renton, Seattle, Tacoma, and surrounding areas to discuss multiple myeloma…
The Christie NHS Foundation Trust has created a supportive oncology program to train fellows and offer services for patients living with cancer.
Dr Tap discusses the significance of this approval, key efficacy and safety data from the phase 3 MOTION trial, and the important role that multidisciplinary…
Nature Reviews Cancer – ALK genetic alterations drive various malignancies through aberrant tyrosine kinase activation, promoting oncogenic cell growth and survival. Here, Voena et al.…
